Panacea Biotec Limited has informed the Exchange about the receipt of rectified Assessment Order dated 06.04.2026 from the Deputy Commissioner of Income Tax. Under this order, the errors have been corrected, and the Company's tax liability for AY 2015-16 has been determined as Nil.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec has received a rectified Assessment Order dated April 6, 2026, from the Deputy Commissioner of Income Tax, New Delhi, for Assessment Year 2015-16. Earlier, on February 27, 2026, the DCIT had raised a tax demand of approximately ₹45.71 crore after disallowing certain expenditures. The company filed a rectification application citing errors such as double addition of disallowances and omission of set-off for brought-forward losses. Following this, the DCIT has corrected these errors and determined the company's tax liability as Nil. The company has confirmed no adverse financial or operational impact is expected from this order.
This is a significant positive outcome for shareholders — the earlier ₹45.71 crore tax demand has been entirely nullified, removing a major potential financial liability. This should be viewed favorably by the market, as it preserves the company's cash flows and earnings for the relevant period.